These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 8875561

  • 1. RRR-alpha-tocopheryl succinate enhances TGF-beta 1, -beta 2, and -beta 3 and TGF-beta R-II expression by human MDA-MB-435 breast cancer cells.
    Charpentier A, Simmons-Menchaca M, Yu W, Zhao B, Qian M, Heim K, Sanders BG, Kline K.
    Nutr Cancer; 1996; 26(2):237-50. PubMed ID: 8875561
    [Abstract] [Full Text] [Related]

  • 2. Evidence for role of transforming growth factor-beta in RRR-alpha-tocopheryl succinate-induced apoptosis of human MDA-MB-435 breast cancer cells.
    Yu W, Heim K, Qian M, Simmons-Menchaca M, Sanders BG, Kline K.
    Nutr Cancer; 1997; 27(3):267-78. PubMed ID: 9101557
    [Abstract] [Full Text] [Related]

  • 3. RRR-alpha-tocopheryl succinate inhibits DNA synthesis and enhances the production and secretion of biologically active transforming growth factor-beta by avian retrovirus-transformed lymphoid cells.
    Simmons-Menchaca M, Qian M, Yu W, Sanders BG, Kline K.
    Nutr Cancer; 1995; 24(2):171-85. PubMed ID: 8584453
    [Abstract] [Full Text] [Related]

  • 4. Modulation of murine EL-4 thymic lymphoma cell proliferation and cytokine production by vitamin E succinate.
    Yu W, Sanders BG, Kline K.
    Nutr Cancer; 1996; 25(2):137-49. PubMed ID: 8710683
    [Abstract] [Full Text] [Related]

  • 5. RRR-alpha-tocopheryl succinate induction of DNA synthesis arrest of human MDA-MB-435 cells involves TGF-beta-independent activation of p21Waf1/Cip1.
    Yu W, Sanders BG, Kline K.
    Nutr Cancer; 2002; 43(2):227-36. PubMed ID: 12588702
    [Abstract] [Full Text] [Related]

  • 6. RRR-alpha-tocopheryl succinate inhibits proliferation and enhances secretion of transforming growth factor-beta (TGF-beta) by human breast cancer cells.
    Charpentier A, Groves S, Simmons-Menchaca M, Turley J, Zhao B, Sanders BG, Kline K.
    Nutr Cancer; 1993; 19(3):225-39. PubMed ID: 8346072
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. RRR-alpha-tocopheryl succinate induction of prolonged activation of c-jun amino-terminal kinase and c-jun during induction of apoptosis in human MDA-MB-435 breast cancer cells.
    Yu W, Simmons-Menchaca M, You H, Brown P, Birrer MJ, Sanders BG, Kline K.
    Mol Carcinog; 1998 Aug; 22(4):247-57. PubMed ID: 9726817
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
    Yu W, Liao QY, Hantash FM, Sanders BG, Kline K.
    Cancer Res; 2001 Sep 01; 61(17):6569-76. PubMed ID: 11522656
    [Abstract] [Full Text] [Related]

  • 11. RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells involves Bax translocation to mitochondria.
    Yu W, Sanders BG, Kline K.
    Cancer Res; 2003 May 15; 63(10):2483-91. PubMed ID: 12750270
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Involvement of activator protein-1 (AP-1) in induction of apoptosis by vitamin E succinate in human breast cancer cells.
    Zhao B, Yu W, Qian M, Simmons-Menchaca M, Brown P, Birrer MJ, Sanders BG, Kline K.
    Mol Carcinog; 1997 Jul 15; 19(3):180-90. PubMed ID: 9254885
    [Abstract] [Full Text] [Related]

  • 14. RRR-alpha-tocopheryl succinate inhibits the proliferation of human prostatic tumor cells with defective cell cycle/differentiation pathways.
    Israel K, Sanders BG, Kline K.
    Nutr Cancer; 1995 Jul 15; 24(2):161-9. PubMed ID: 8584452
    [Abstract] [Full Text] [Related]

  • 15. Vitamin E succinate promotes breast cancer tumor dormancy.
    Malafa MP, Neitzel LT.
    J Surg Res; 2000 Sep 15; 93(1):163-70. PubMed ID: 10945959
    [Abstract] [Full Text] [Related]

  • 16. Expression of transforming growth factor beta ligand and receptor messenger RNAs in lung cancer cell lines.
    Jakowlew SB, Mathias A, Chung P, Moody TW.
    Cell Growth Differ; 1995 Apr 15; 6(4):465-76. PubMed ID: 7794814
    [Abstract] [Full Text] [Related]

  • 17. Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells.
    Sheikh MS, Shao ZM, Hussain A, Clemmons DR, Chen JC, Roberts CT, LeRoith D, Fontana JA.
    J Cell Physiol; 1993 Jun 15; 155(3):556-67. PubMed ID: 7684042
    [Abstract] [Full Text] [Related]

  • 18. Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: role for transforming growth factor beta.
    Turley JM, Funakoshi S, Ruscetti FW, Kasper J, Murphy WJ, Longo DL, Birchenall-Roberts MC.
    Cell Growth Differ; 1995 Jun 15; 6(6):655-63. PubMed ID: 7669719
    [Abstract] [Full Text] [Related]

  • 19. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells.
    Gucev ZS, Oh Y, Kelley KM, Rosenfeld RG.
    Cancer Res; 1996 Apr 01; 56(7):1545-50. PubMed ID: 8603400
    [Abstract] [Full Text] [Related]

  • 20. Differential response of human ovarian cancer cells to induction of apoptosis by vitamin E Succinate and vitamin E analogue, alpha-TEA.
    Anderson K, Simmons-Menchaca M, Lawson KA, Atkinson J, Sanders BG, Kline K.
    Cancer Res; 2004 Jun 15; 64(12):4263-9. PubMed ID: 15205340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.